This study evaluated the effectiveness of COVID-19 vaccines in preventing symptomatic and severe disease. This was an observational test-negative case-control study. Study participants were adults with at least one symptom included in the World Health Organization COVID-19 definition who sought health care in a public emergency department between 1 November 2021 and 2 March 2022 (corresponding with the fifth pandemic wave in Portugal dominated by the Omicron variant). This study used multivariable logistic regression models to estimate and compare the odds ratio of vaccination between test-positive cases and test-negative controls to calculate the absolute and relative vaccine effectiveness. The study included 1059 individuals (522 cases and 537 controls) with a median age of 56 years and 58% were women. Compared with the effectiveness of the primary vaccination scheme that had been completed ≥180 days earlier, the relative effectiveness against symptomatic infection of a booster administered between 14 and 132 days earlier was 71% (95% confidence interval [CI]: 57%, 81%; P < 0.001). The effectiveness of the primary series against symptomatic infection peaked at 85% (95% CI: 56%, 95%) between 14 and 90 days after the last inoculation and decreased to 34% (95% CI: -43%, 50%) after ≥180 days. Despite the known immunological evasion characteristics of the Omicron variant, results from this study show that vaccine effectiveness increases after booster administration. COVID-19 vaccine effectiveness decreases to less than 50% between 3 and 6 months after completion of the primary cycle; therefore, this would be an appropriate time to administer a booster to restore immunity.
12 May 2025 in The Journal of the International Society of Physical and Rehabilitation Medicine
The understanding of spasticity has evolved to recognize the complex interaction between hyperkinetic and hypokinetic mechanisms. Disruptions in upper motor neurons lead to an imbalance in excitatory and inhibitory pathways, increasing muscle tone and hyperreflexia, while hypokinetic factors contribute to structural decline. This article presents a case-based framework that integrates visual aids to support a patient-centered, goal-oriented, and multimodal treatment approach addressing both hyperkinetic and hypokinetic components. By combining pharmacological, orthotic, and rehabilitative interventions, this strategy improves clinical and functional outcomes. The authors endorse this evidence-based approach, offering a practical model adaptable across health care settings for clinicians worldwide.
The demand for physical medicine and rehabilitation services has risen significantly. Immediate rehabilitation is not always readily available which may compromise patients' functional recovery. Here, we describe a rare subtalar dislocation case and how an unsupervised home-based rehabilitation program allowed functional recovery. A 49-year-old male presented to the emergency department with an injury to the right ankle which resulted from a 3-meter height fall with his foot in plantar flexion and inversion. Clinical and imaging findings confirmed a diagnosis of a rare case of subtalar dislocation. The post-injury AOFAS Ankle-Hindfoot Scale score was 24/100 points. After six weeks of immobilization, a patient-tailored home-based rehabilitation program was prescribed. Adherence to our home-based rehabilitation program was critical to allow a range-of-motion improvement and functional recovery. Delaying rehabilitation may lead to long-term functional impairments. Thus, acknowledging the post-acute period as critical to initiate rehabilitation is mandatory. When outpatient rehabilitation settings are not readily available due to high demand, comprehensive patient education, and home-based rehabilitation programs may constitute effective alternative interventions. We demonstrate the significant improvement obtained with an early patient-tailored home-based rehabilitation program in range-of-motion and functional outcomes in a case of medial subtalar dislocation.
BACKGROUND The Michigan Hand Outcomes Questionnaire (MHQ) is a key instrument for assessing hand and wrist conditions, but a validated version for European Portuguese speakers is unavailable. Furthermore, the potential of an electronic format to improve data collection and clinical workflows has not been formally evaluated. OBJECTIVE This study aimed to translate and culturally adapt the MHQ for European Portuguese and to evaluate the measurement properties and comparability of its paper and electronic formats. METHODS An observational study was conducted in three phases: (1) translation and expert review, (2) content validation through cognitive interviews, and (3) psychometric evaluation in a cohort of 81 adult patients with hand or wrist conditions. Exploratory known-groups analyses were performed according to clinical, sociodemographic, and digital-access variables. Analysis also included internal consistency (Cronbach α and McDonald ω), measurement error (standard error of measurement [SEM]), relative and absolute reliability (intraclass correlation coefficient [ICC], Spearman correlation coefficient [ρ], and Bland-Altman analysis). The electronic format’s usability was assessed with the System Usability Scale (SUS). RESULTS The translation and cognitive interviews confirmed the content validity and conceptual equivalence of the European Portuguese MHQ. The instrument demonstrated excellent internal consistency (Cronbach α=0.85-0.98; McDonald ω=0.88-0.99). Exploratory known-groups analyses showed significant gender-related differences and suggested side-specific clinical discrimination in fracture cases. While group-level relative reliability between formats was strong (ρ=0.68-0.91; ICC=0.76-0.95), individual-level absolute reliability was poor, with wide 95% limits of agreement spanning a 32.83-point interval. Format-related score discrepancies were most pronounced among older participants, those with lower educational attainment, and those with low digital literacy. The electronic MHQ was the preferred format (43 out of 74, 58%), showed acceptable usability (median SUS score 70, IQR 66-88), and had lower SEM in pain and function domains. CONCLUSIONS The European Portuguese MHQ is a relevant and reliable instrument with adequate measurement properties for both clinical practice and research. The electronic version demonstrated superior precision and user preference. However, maintaining the paper format as a viable alternative is essential to ensure equitable access for patients with digital barriers. Due to the overall low absolute reliability between formats, once a patient-preferred format is adopted, it should be used consistently for longitudinal patient monitoring. CLINICALTRIAL